Recent Quarter Total Invested
$226
-$351,774.00
Recent Quarter Institutional Ownership Percentage
0.01%
-$4.77
Total Invested of Last Quarter
$352,000
Ownership Percentage of Last Quarter
4.78%
Baudax Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
EDMOND DE ROTHSCHILD HOLDING S.A. | 02/09/2023 | 71 | $226 | -97.51% | 0.01% |
JPMORGAN CHASE & CO | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
BLACKROCK INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
SABBY MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
WARBERG ASSET MANAGEMENT LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
DYNAMIC ADVISOR SOLUTIONS LLC | 01/13/2023 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
SITTNER & NELSON, LLC | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
Baudax Bio, Inc.institutional Ownership - Frequently Asked Questions
-
What percentage of Baudax Bio, Inc. stock is owned by institutional investors?
0.01% of Baudax Bio, Inc. stock is owned by institutional investors.